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ABSTRACT 
Phelan-McDermid syndrome, also known as 22q13.3 deletion syndrome, is characterized by global developmental 
delay, absent or delayed speech, generalized hypotonia, and minor physical anomalies. The deletion typically involves 
the terminal band 22q13.3 and has been associated with both familial and de-novo translocations. We report the case of 
an 11-year-old Turkish girl with 22q13.3 deletion syndrome presenting with repeated seizures during the course of a 
rubella infection. We also review the clinical features of 22q13.3 deletion syndrome and emphasize the importance of 
considering a rare microdeletion syndrome for idiopathic mental retardation when results of a routine karyotype analysis 
are normal. To the best of our knowledge, this is the first reported case of a Turkish patient with isolated 22q13.3 
deletion syndrome.   
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ÖZET 
Phelan-McDermid sendromu olarak da bilinen 22q13.3 delesyon sendromu, global gelişme geriliği, gecikmiş ve 
gelişmemiş konuşma, jenaralize hipotoni ve minör fiziksel anomaliler ile karekterizedir. Delesyon tipik olarak 22q13.3'ün 
terminal bandını içermekte ve ailesel veya denova translokasyon ile ilişkilidir. Bu yazıda 11 yaşında, Rubella  
enfeksiyonu esnasında tekrarlayan nöbetlerle başvurduğu sırada   22q13.3 delesyon sendromu tanısı konulan bir türk 
kız hasta sunulmuştur. Ayrıca 22q13.3 delesyon sendromun klinik bulgularıda derlenerek, karyotip analizi normal olan 
idyopatik mental retardasyonu olan olgularda microdelesyon sendromlarının önemine dikkat çekilmiştir. Bilgilerimiz 
dahilinde, bu olgu ilk izole 22q13.3 delesyon sendromu olan Türk hastadır. 
Anahtar kelimeler: 22q13.3 delesyon sendromu, afazi, epilepsi, mental retardasyon 
INTRODUCTION 
 Recent advances in genetic testing can help 
provide a specific diagnosis for children born with 
congenital anomalies and who show subsequent 
developmental delay. The introduction of 
subtelomeric fluorescence in-situ hybridization 
(FISH) analysis has revealed 22q13.3 deletion as  
 
a relatively widespread and underdiagnosed cause 
of mental retardation1,2. However, the true 
prevalence of 22q13.3 deletion syndrome remains 
unknown.  
 The 22q13.3 deletion syndrome is 
characterized by neonatal hypotonia, global 
developmental delay, absent to severely delayed 
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speech, autistic behavior, normal to accelerated 
growth, and minor physical anomalies including 
dolichocephaly, abnormal ears, ptosis, puffy 
eyelids, wide nasal bridge, puffy cheeks, pointed 
chin, dysplastic toe nails, and relatively large 
hands1,2. Most individuals have severe to profound 
mental retardation, while a minority are in the mild 
to moderate range. The deletion typically involves 
the terminal band of the 22q13.3 region and is 
usually the result of de novo translocation of the 
paternal chromosome, although familial inheritance 
has been described1-3. In general, the severity of 
the neurological deficit is not well correlated with 
the deletion span but rather on the deletion of the 
autism-associated SH3 and multiple ankyrin repeat 
domains 3 protein (Shank3)4. 
CASE REPORT 
 An 11-year-old girl with mental and motor 
retardation was admitted to our hospital with fever, 
rash, and seizures. She had been febrile for four 
days and had maculopapular lesions for the 
previous three days. On the day of admission, she 
had an afebrile generalized, tonic-clonic seizure 
that lasted nearly 10 minutes.  
 The patient was the first child of 
nonconsanguineous parents; her mother was 30 
years of age and her father was 38. She had been 
born at term by vaginal delivery. Her birth weight, 
length, and head circumference were not recorded. 
The pregnancy was uncomplicated, and there was 
no history of maternal teratogenic agent exposure. 
Her neuromotor development was delayed and 
she had marked mental retardation. She was 
unable to talk, except for a few words. The patient 
had been diagnosed at another center with 
idiopathic mental retardation associated with 
severely compromised language development and 
dysmorphic features. On admission, her weight 
was 42 kg (within the 50th–75th percentile for her 
age), her length was 150 cm (within the 75th–90th 
percentile for her age), and her head 
circumference was 52 cm. Dysmorphic features 
included an elongated face with thick eyebrows, a 
smooth philtrum, a thin upper lip, narrow palpebral 
fissures, broad nasal root, and mild micrognathia 
(Figures 1A-B). On neurologic examination, 
generalized tonic-clonic seizure activity with a loss 
of consciousness was observed. The results of an 
ophthalmologic examination were unremarkable. 
There was no focal neurologic deficit or meningeal 
irritation. Laboratory analyses determined that 
serum C-reactive protein (3 mg/L), erythrocyte 
sedimentation (15 mm/h), complete blood count, 
thyroid functioning, and standard blood chemistry 
values (including lactate, pyruvate, ammonia, and 
amino acids) were within normal ranges. Neither 
computed tomography nor magnetic resonance 
imaging revealed any gross structural 
abnormalities in the brain. An 
electroencephalogram showed diffuse slowing 
without an epileptic abnormality. The results of a 
cerebrospinal fluid examination were normal. 
Tandem mass spectrometry of the blood was 
negative for organic acid and acylcarnitine 
abnormalities. Results of cold agglutinin, Gruber-
Widal agglutination, and brucella agglutination 
tests were all negative. Acyclovir and ceftriaxone 
were given empirically. Serologic tests were 
negative for cytomegalovirus, herpes virus, and 
parvovirus B19, but positive for Rubella IgM and 
IgG on the third day of admission. Cerebrospinal 
fluid serologic titers for Rubella Ig M and G were 
negative. 
 Phenytoin was given at a bolus dose of 20 
mg/kg and a maintenance dosage of 6 mg/kg/day 
after the seizure; however, the seizure reoccurred 
several times during the next two days. Valproic 
acid was added to the regimen, and seizure control 
was achieved. The patient began to improve on 
the fourth day of hospitalization. The antibiotic and 
antiviral treatment was completed in 10 days. 
Results of the patient’s hearing tests and 
echocardiography were normal. Her global IQ 
score was 45 as assessed by the Wechsler 
Intelligence Scale for Children-Revised. 
 Cytogenetic analyses performed on a 
peripheral blood lymphocyte sample by the 
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Giemsa-trypsin banding method revealed a normal 
karyotype.5 Dysmorphic findings of the patient led 
us to perform a FISH analysis to test for 
DiGeorge/velocardiofacial syndrome (VCFS). The 
probe, an LSI TUPLE1 (HIRA) DiGeorge region 
probe with an LSI ARSA control probe (Vysis Inc., 
Downers Grove, IL, USA) revealed 22q11.2 
(HIRA×2), del(22)(q13.3)(ARSA-). We therefore 
diagnosed 22q13.3 deletion syndrome as the 
cause of the patient’s delayed speech, mental and 
motor retardation, and dysmorphic features.  
 
 
Figure 1 A-B. Frontal and lateral view of the patient at 11 years of age showing the elongated face with thick eyebrows, 
smooth philtrum, thin upper lip, narrow palpebral fissures, broad nasal root, and mild micrognathia. 
DISCUSSION 
 The 22q13.3 deletion syndrome is 
characterized by global developmental delay, 
generalized hypotonia, absent or delayed speech, 
normal to advanced growth, and minor anomalies 
of the face, head, ears, hands, and feet.1 Seizures 
have been described in 27% of children with the 
22q13.3 deletion.2 We report the case of an 11-
year-old child with 22q13.3 deletion syndrome 
presenting with repeated seizures during the 
course of a rubella infection.  
 The first case of pure 22q13.3 deletion was 
described in 1985 by Watt and associates.3 in a 
14-year-old boy exhibiting profound mental 
retardation, absent speech, and minor dysmorphic 
features. Phelan and associates6 were the first to 
describe generalized hypotonia in association with 
the terminal deletion of 22q13.3 in a newborn boy.  
They later identified the breakpoint at 22q13.31. At 
26 months, this boy had normal growth but with  
developmental delay and diffuse hypotonia. Prior 
to 1994, only 8 patients had been diagnosed with 
this disorder. In 1994, Nesslinger and associates 
suggested that the 22q13.3 deletion was a 
recognizable clinical syndrome characterized by 
global developmental delay, severe delay in 
expressive speech, normal or accelerated growth, 
and generalized hypotonia with minor facial 
anomalies.7 The present case shared many of 
these features but exhibited normal growth and 
head circumference.  
 The largest study to date was reported by 
Phelan and associates in 20011. They defined 37 
individuals with 22q13.3 deletion and compared 
them with 24 previously published cases. The 
major findings of global developmental delay, 
generalized hypotonia, absent or delayed speech, 
and normal to advanced growth were confirmed by 
this study. The authors also identified common 
minor anomalies of the face, head, ears, hands, 
and feet. Only 32% of the individuals in this sample 
had prior genetic evaluations and normal standard 
chromosome analyses, suggesting that 22q13.3 
deletion syndrome remains underdiagnosed. 
Similarly, the present patient had a normal 
standard chromosome analysis but was never 
tested for microdeletions.  
 Seizures have been described in 27% of 
children with 22q13.3 deletion2 but there are no 
characteristic electroencephalographic features 
that distinguish 22q13.3 deletion syndrome. High 
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voltage polymorphic delta activity and 
parietotemporal spikes and waves have been 
reported in patients with the 22q13.3 deletion 
syndrome but these are not distinguishing 
features8,9. Similarly, our patient had unremarkable 
changes in her electroencephalogram, and her 
seizures responded well to phenytoin and valproic 
acid. The patient had been examined previously at 
another hospital for mental retardation, severely 
compromised language development, and 
dysmorphic features, but 22q13.3 deletion 
syndrome was not considered until she was 
admitted to our institute with repeated seizures 
during rubella infection. 
 Diagnosis of the 22q13.3 deletion syndrome 
is established only by demonstrating a deletion or 
disruption of 22q13.3 by routine chromosome 
analysis or FISH testing1,2. Although our patient 
fulfilled the diagnostic criteria for 22q13.3 deletion 
syndrome (severely compromised language 
development, dysmorphic features, mental 
retardation, and seizures), she was diagnosed 
serendipitously after the telomeric control probe 
signal at 22q13.3 was absent on a FISH test for 
DiGeorge/VCFS (22q11.2 deletion syndrome). 
Similarities between VCFS 22q11.2 deletion 
syndrome and 22q13.3 deletion syndrome include 
hypotonia, epicanthal folds, narrow palpebral 
fissures, broad nasal root, speech delay, renal 
abnormalities, and developmental delay2,10-12. The 
neurologic problems observed in VCFS are not as 
severe as those in the 22q13.3 deletion 
syndrome13. Hypotonia, epicanthal folds, narrow 
palpebral fissures, broad nasal root, and speech 
delay were the most significant symptomes in our 
patient, so we performed a FISH analysis for the 
22q11.2 deletion. Velocardiofacial syndrome is 
frequently associated with cardiac and/or palatal 
defects, immune deficiency, and hypocalcemia, 
however, and these symptoms are absent in 
22q13.3 deletion syndrome including the case 
described here. The 22q11.2 deletion syndrome is 
diagnosed by FISH using the N25 or Tuple probe 
set with ARSA as the control probe because ARSA 
maps to 22q13. The N25 or Tuple probe set has 
detected the deletion of 22q13, resulting in the 
diagnosis of the 22q13.3 deletion syndrome in 
several individuals tested for VCFS1,2,4,9,10. Precht 
and associates serendipitously also detected 
22q13.3 deletion in one child by a FISH analysis 
for 22q11.2 DiGeorge/ VCFS10. 
 In 1995, Flint and associates developed a 
strategy to simultaneously screen 28 subtelomeric 
regions of the human chromosomes, including 
22q11. They studied 99 patients with idiopathic 
mental retardation of varying degrees and detected 
submicroscopic deletion of 22q13.3 in two patients. 
The authors emphasized the importance of 
analyzing variations involving the ends of 
chromosomes, and in particular, testing for the 
22q13.3 deletion in individuals with idiopathic 
mental retardation.  
 Determining the etiology of idiopathic mental 
retardation is a frequent and challenging problem 
in pediatric neurology. Clinicians should consider 
screening for 22q13.3 deletion syndrome in any 
child with hypotonia, persistent lack of speech, and 
global developmental delay, particularly if the 
routine karyotype is normal. There is no specific 
therapy for 22q13.3 deletion syndrome, but early 
rehabilitative and educational interventions 
improve the prognosis and considerable progress 
has been made in the social adjustment of 22q13.3 
deletion syndrome patients.  
 Koç A et al. reported a patient with ring 
chromosome 22 associated with 22q13.3 deletion. 
Their patient had the major features of ring 
chromosome 22, including mental retardation, 
hypotonia, motor delay, microcephaly, dysplastic 
large ears, lack of speech, and hyperactivity 
disorder14. Since our patient had normal karyotype 
analysis, she is the first reported case of a Turkish 
patient with isolated 22q13.3 deletion syndrome.   
 In conclusion, although the dysmorphic 
features observed in this condition are nonspecific, 
they can aid in the differential diagnosis of children 
with developmental delay, hypotonia, marked 
speech and language disability, autistic features, 
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and normal growth and head circumference. We 
recommend high resolution chromosome analysis, 
FISH studies or molecular analyses to exclude this 
diagnosis in patients with idiopathic mental 
retardation, especially when associated with 
severely compromised language development.  
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